Echo Street Capital Management LLC Incyte Corp Transaction History

Echo Street Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$57.77 - $65.93 $498,439 - $568,844	-8,628 Reduced 41.17%	12,329 $712,000
Q2 2023 Aug 11, 2023	BUY	$60.95 - $75.51 $795,397 - $985,405	13,050 Added 165.04%	20,957 $1.3 Million
Q1 2023 May 12, 2023	BUY	$70.23 - $86.01 $555,308 - $680,081	7,907 New	7,907 $571,000
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $880,061 - $1.1 Million	13,298 New	13,298 $886,000
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $278,750 - $350,354	-4,212 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $167,888 - $202,702	-2,543 Reduced 37.65%	4,212 $335,000
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $239,931 - $280,728	3,788 Added 127.67%	6,755 $496,000
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $82,816 - $101,328	-1,206 Reduced 28.9%	2,967 $204,000
Q2 2021 Aug 16, 2021	BUY	$79.87 - $87.53 $333,297 - $365,262	4,173 New	4,173 $351,000

645

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.